Fortress Biotech (FRA:CNB1) Price-to-Operating-Cash-Flow : (As of May. 28, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Fortress Biotech Price-to-Operating-Cash-Flow?

As of today (2024-05-28), Fortress Biotech's share price is €4.131. Fortress Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-12.46. Hence, Fortress Biotech's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Fortress Biotech's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:CNB1's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.25
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Fortress Biotech's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-2.61. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-12.46.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 3.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -8.90% per year.

During the past 13 years, Fortress Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 32.00% per year. The lowest was -63.50% per year. And the median was -0.40% per year.

Fortress Biotech Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Fortress Biotech's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech Price-to-Operating-Cash-Flow Chart

Fortress Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Fortress Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Fortress Biotech's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Fortress Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fortress Biotech's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortress Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fortress Biotech's Price-to-Operating-Cash-Flow falls into.

Fortress Biotech Price-to-Operating-Cash-Flow Calculation

Fortress Biotech's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	4.131	/	-12.46
	=

Fortress Biotech's Share Price of today is €4.131.
Fortress Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.46.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Fortress Biotech Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortress Biotech (FRA:CNB1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (FRA:CNB1) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

FBIOP.PFD:USA FBIO:USA CNB0.PFD:Germany

Address

1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website

https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Fortress Biotech (FRA:CNB1) Headlines

No Headlines